Citation

Guo L, Parker DL, Zang Y, Sweis RF, Liu W, Sherer EC, Buist N, Terebetski J, Kelly T, Bugianesi R, Priest BT, Dingley KH, Li X, Mitelman S, Salituro G, Trujillo ME, Pachanski M, Kirkland M, Powles MA, Eiermann GJ, Feng Y, Shang J, Howard AD, Ujjainwalla F, Sinz CJ, Debenham JS, Edmondson SD, Nargund RP, Hagmann WK, Li D.: Discovery and Optimization of a Novel Triazole Series of GPR142 Agonists for the Treatment of Type 2 Diabetes. ACS Med Chem Lett, Volume 7 (12), 2016

Authors

Bugianesi R, Buist N, Debenham JS, Dingley KH, Edmondson SD, Eiermann GJ, Feng Y, Guo L, Hagmann WK, Howard AD, Kelly T, Kirkland M, Li D., Li X, Liu W, Mitelman S, Nargund RP, Pachanski M, Parker DL, Powles MA, Priest BT, Salituro G, Shang J, Sherer EC, Sinz CJ, Sweis RF, Terebetski J, Trujillo ME, Ujjainwalla F, Zang Y

Journal

ACS Med Chem Lett

Year

2016

DOI

10.1021/acsmedchemlett.6b00314

PubMed

27994747

Machine-readable

REST APIRDF